Lebovits Chaim's Form 4 filing
Brainstorm Cell Therapeutics Inc. (BCLI) · filed Oct 2, 2024
- Accession no.
- 0001104659-24-105215
- Filed
- Oct 2, 2024, 8:00 AM ET
- Trade date
- Sep 30-Oct 1, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $11.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lebovits ChaimCIK 0001406302 | Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | Common Stock | PPurchaseAcquired | +22,000 | $0.228 | +$5,016 | 1,186,865 | Direct | |
| Oct 1, 2024 | Common Stock | PPurchaseAcquired | +1,836 | $3.43 | +$6,292.34 | 80,960 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.